Overview

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Status:
RECRUITING
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
The present investigation is designed as a single-blind, randomized, controlled, bicentric trial. The objective is to ascertain whether the subcutaneous administration of enoxaparin sodium for prophylactic anticoagulation during transradial hepatic arterial infusion chemotherapy (HAIC) can diminish the incidence of radial artery occlusion (RAO) post-procedure
Phase:
PHASE2
Details
Lead Sponsor:
Zhongshan Hospital (Xiamen), Fudan University